Franz Bergmann studied bioinformatics at the Technical University of Munich and Ludwig Maximilians University Munich. Already during his studies he worked as a junior consultant in the field of databases & reporting. He completed his doctorate in microbiology and isotope geochemistry at the HelmholtzZentrum München and TU München. Subsequently, he worked as a life science consultant with a focus on due diligence evaluation, market analysis and drug logistics. Joining advanceCOR GmbH in 2012, he took over the handling of project transfer in the context of the sale to Janssen-CILAG/Johnson & Johnson, as well as the management of clinical development and GCP.
Franz Bergmann joined the ISAR Bioscience team in January 2021 and coordinates the research alliance “BASE-Lipid”. In addition, he is responsible for finances including third-party funding as well as spin-off conception.